DE602005017626D1 - Antivirale verwendung von borinsäurekomplexen - Google Patents

Antivirale verwendung von borinsäurekomplexen

Info

Publication number
DE602005017626D1
DE602005017626D1 DE602005017626T DE602005017626T DE602005017626D1 DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1 DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1
Authority
DE
Germany
Prior art keywords
acid complexes
borinic acid
antiviral use
antiviral
borinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005017626T
Other languages
German (de)
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals LLC
Original Assignee
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC
Publication of DE602005017626D1 publication Critical patent/DE602005017626D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005017626T 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen Expired - Lifetime DE602005017626D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
DE602005017626D1 true DE602005017626D1 (de) 2009-12-24

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017626T Expired - Lifetime DE602005017626D1 (de) 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen

Country Status (12)

Country Link
US (1) US7393856B2 (https=)
EP (1) EP1765360B1 (https=)
JP (1) JP2008502694A (https=)
AT (1) ATE447960T1 (https=)
BR (1) BRPI0512049A (https=)
CA (1) CA2570577A1 (https=)
DE (1) DE602005017626D1 (https=)
ES (1) ES2333244T3 (https=)
MX (1) MXPA06014417A (https=)
PT (1) PT1765360E (https=)
TW (1) TW200612967A (https=)
WO (1) WO2006085932A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070179296A1 (en) * 2005-12-28 2007-08-02 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
ME02188B (me) 2006-02-16 2016-02-20 Anacor Pharmaceuticals Inc Mali molekuli koji sadrže boron kao antiinflamatorni agensi
WO2010018836A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 ポリグルタミン凝集阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US9138001B2 (en) 2013-01-30 2015-09-22 Agrofresh Inc. Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
TWI794742B (zh) * 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002424A2 (en) 1999-07-07 2001-01-11 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
JP2006511613A (ja) * 2002-12-18 2006-04-06 アナコア ファーマシューティカルズ インコーポレイテッド ボロン酸複合体を含む抗生物質および使用法

Also Published As

Publication number Publication date
ATE447960T1 (de) 2009-11-15
PT1765360E (pt) 2009-12-24
EP1765360A2 (en) 2007-03-28
JP2008502694A (ja) 2008-01-31
WO2006085932A3 (en) 2006-10-05
US20060019927A1 (en) 2006-01-26
EP1765360B1 (en) 2009-11-11
TW200612967A (en) 2006-05-01
MXPA06014417A (es) 2007-03-08
WO2006085932A2 (en) 2006-08-17
HK1102702A1 (en) 2007-11-30
ES2333244T3 (es) 2010-02-18
BRPI0512049A (pt) 2008-02-06
US7393856B2 (en) 2008-07-01
CA2570577A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
EA200802213A1 (ru) Способы лечения заболеваний крови
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
DE602005017626D1 (de) Antivirale verwendung von borinsäurekomplexen
DE50310516D1 (de) Fredericamycin-derivate
EA201170521A1 (ru) Новые соединения
WO2006007384A3 (en) Antibiotics containing borinic acid complexes and methods of use
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
NO20060091L (no) Anvendelse av kondenserte heterocykliske forbindelser som SCCE-inhibitorer for behandling av hudproblemer eller kreft
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
DK1558616T3 (da) Meso-substituerede porphyriner
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
DE502006002886D1 (de) Dipyridyl-dihydropyrazolone und ihre verwendung 4- (pyridin-3-yl) -2- (pyridin-2-yl) -1,2-dihydro-3h-pyrazol-3-on derivate als spezifische hemmstoffe der hif-prolyl-4-hydroxylasen zur behandlung kardiovaskulärer und hämatologischer erkrankungen
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
DE602004024037D1 (de) Substituierte heterozyklen
TW200509892A (en) Novel aminobenzophenone compounds
BR0310055A (pt) Derivados de piridinacarboxamida pesticidas
DK1594885T3 (da) Lægemiddel til vækstinhibering af tumorer
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
ATE445406T1 (de) Verwendung von eisen(iii)-komplexverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition